Antigenic cartography of immune responses to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)


PLoS Pathog

Naturally acquired clinical immunity to Plasmodium falciparum is partly mediated by antibodies directed at parasite-derived antigens expressed on the surface of red blood cells which mediate disease and are extremely diverse. Unlike children, adults recognize a broad range of variant surface antigens (VSAs) and are protected from severe disease. Though crucial to the design and feasibility of an effective malaria vaccine, it is not yet known whether immunity arises through cumulative exposure to each of many antigenic types, cross-reactivity between antigenic types, or some other mechanism. In this study, we measured plasma antibody responses of 36 children with symptomatic malaria to a diverse panel of 36 recombinant proteins comprising part of the DBLalpha domain (the ‘DBLalpha-tag’) of PfEMP1, a major class of VSAs. We found that although plasma antibody responses were highly specific to individual antigens, serological profiles of responses across antigens fell into one of just two distinct types. One type was found almost exclusively in children that succumbed to severe disease (19 out of 20) while the other occurred in all children with mild disease (16 out of 16). Moreover, children with severe malaria had serological profiles that were narrower in antigen specificity and shorter-lived than those in children with mild malaria. Borrowing a novel technique used in influenza-antigenic cartography-we mapped these dichotomous serological profiles to amino acid sequence variation within a small sub-region of the PfEMP1 DBLalpha domain. By applying our methodology on a larger scale, it should be possible to identify epitopes responsible for eliciting the protective version of serological profiles to PfEMP1 thereby accelerating development of a broadly effective anti-disease malaria vaccine.

Tuju, J., Mackinnon, M. J., Abdi, A. I., Karanja, H., Musyoki, J. N., Warimwe, G. M., Gitau, E. N., Marsh, K., Bull, P. C., Urban, B. C.

Pages:e1007870, Volume:15, Edition:7/2/2019, Date,Jul


Notes:Tuju, James|Mackinnon, Margaret J|Abdi, Abdirahman I|Karanja, Henry|Musyoki, Jennifer N|Warimwe, George M|Gitau, Evelyn N|Marsh, Kevin|Bull, Peter C|Urban, Britta C|eng|092741 /WT_/Wellcome Trust/United Kingdom|084535/WT_/Wellcome Trust/United Kingdom|077176 /WT_/Wellcome Trust/United Kingdom|WT_/Wellcome Trust/United Kingdom|079082 /WT_/Wellcome Trust/United Kingdom|079082/WT_/Wellcome Trust/United Kingdom|084535 /WT_/Wellcome Trust/United Kingdom|Research Support, Non-U.S. Gov’t|2019/07/02 06:00|PLoS Pathog. 2019 Jul 1;15(7):e1007870. doi: 10.1371/journal.ppat.1007870. eCollection 2019 Jul.

ISBN: 1553-7374 (Electronic)|1553-7366 (Linking) Permanent ID: PMC6625739 Accession Number: 31260501

Author Address: KEMRI-Wellcome Trust Research Programme, Kenya.|Department of Chemistry and Biochemistry, Pwani University, Kilifi, Kenya.|Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.|African Population and Health Research Center, Nairobi, Kenya.|Liverpool School of Tropical Medicine, Department of Tropical Disease Biology, Pembroke Place, Liverpool, United Kingdom.